Moderate

Focal atrial tachycardia

Non-reentrant atrial tachycardia · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Focal atrial tachycardia arises from a single ectopic atrial focus producing a regular narrow-complex tachycardia with abnormal P-wave morphology. It may be incessant and cause a tachycardia-mediated cardiomyopathy if untreated.

Red flags

  • Incessant tachycardia with falling LV function
  • Haemodynamic instability
  • Tachycardia in the context of digoxin toxicity
  • Syncope or pre-syncope
  • Failure to respond to multiple drugs

Assessment

Differential diagnosis

  • AVNRT
  • AVRT
  • Atrial flutter
  • Sinus tachycardia
  • Multifocal atrial tachycardia
  • Junctional tachycardia

Investigations

  • 12-lead ECG (P-wave axis/morphology differs from sinus)
  • Ambulatory monitor to capture onset/termination
  • Echocardiogram for LV function
  • Electrolytes including magnesium and potassium
  • TFTs
  • Electrophysiology study to localise the focus

Management

  • Confirm a regular atrial tachycardia with abnormal P-wave morphology
  • Identify warm-up/cool-down behaviour distinguishing it from re-entry
  • Correct electrolyte disturbance and remove triggers (stimulants, digoxin toxicity)
  • Assess LV function for tachycardia-mediated cardiomyopathy
  • For acute control use vagal manoeuvres and adenosine (may terminate or reveal atrial activity)
  • Rate-control with a beta-blocker or non-dihydropyridine calcium blocker
  • Add an antiarrhythmic (flecainide or sotalol) if rate control inadequate
  • Refer incessant or drug-refractory cases for catheter ablation
  • Treat any reversible cause such as digoxin toxicity directly
  • Re-image LV function after rhythm control to confirm recovery
  • Counsel on recurrence and symptom monitoring
  • Arrange electrophysiology follow-up

Drugs & doses

Metoprolol 25-100 mg PO BD (or bisoprolol 2.5-10 mg OD)
Verapamil SR 120-240 mg PO OD (if EF preserved)
Flecainide 50-150 mg PO BD (no structural heart disease)
Sotalol 80-160 mg PO BD
Adenosine 6 mg IV rapid push then 12 mg (diagnostic/therapeutic, acute)

Disposition

Cardiology/electrophysiology outpatient referral; ablation for refractory or incessant cases. Admit if haemodynamically unstable or cardiomyopathy.

Complications & pitfalls

  • Tachycardia-mediated cardiomyopathy
  • Heart failure
  • Proarrhythmia from antiarrhythmics
  • Recurrence after medical therapy
  • Atrial remodelling

Exam pearls

  • Unlike AVNRT/AVRT, adenosine may transiently block the AV node and unmask ongoing atrial activity rather than terminate it
  • Catheter ablation has high success for a single focus and is preferred for incessant disease
  • Suspect digoxin toxicity when atrial tachycardia occurs with AV block
  • Tachycardia-mediated cardiomyopathy reverses once rhythm is controlled
  • P-wave morphology helps localise the focus before ablation

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.